Product Images Memantine Hydrochloride
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 8 images provide visual information about the product associated with Memantine Hydrochloride NDC 69680-162 by Vitruvias Therapeutics, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Memantine HCl Extended-Release Capsules 14 mg - 14mg
Each capsule of this medication contains 14 mg of memantine HCI. The usual dosage and other important information can be found in the package insert. It is important to keep this medication out of the reach of children and store it in a tightly closed container as per the instructions in the USP. The recommended storage temperature is 25°C (77°F), with excursions permitted to 15-30°C (59-86°F). The medication is manufactured by Xiamen LP Pharmaceutical Co., Ltd. in China and distributed by Viruvias Therapeutics in the USA. The product is an extended-release capsule formulation of memantine hydrochloride. The package contains 30 capsules. The information includes a unique identification number (GTIN), serial number (SN), expiration date (EXP), and lot number (LOT).*
Memantine HCl Extended-Release Capsules 28 mg - 28mg
Each capsule of this medication contains 28 mg of memantine hydrochloride. The recommended dosage can be found in the package insert. Keep the drug out of the reach of children and store it in a tightly closed container at a temperature of 25°C (77°F), with excursions permitted between 15-30°C (59-86°F). This drug is distributed by Vitruvias Therapeutics P LA and manufactured by Xiamen LP Pharmaceutical Co., Ltd in Xiamen, Fujian, China. It is an extended-release capsule for once-daily use. The package contains 30 capsules of 28mg each. The product is only available with a prescription. Additional information such as GTIN, SN, EXP, and LOT numbers are also provided.*
Memantine HCl Extended-Release Capsules 7 mg - 7mg
Each capsule of this medication contains 7 mg of memantine hydrochloride. The recommended storage temperature is 25°C (77°F), with permitted excursions between 15-30°C (59-86°F). Please refer to the package insert for full prescribing information, and keep this and all drugs out of the reach of children. The medication is supplied in a tightly closed container as described in the USP. It is manufactured by Xiamen LP Pharmaceutical Co., Ltd in China and distributed by Vitruvias Therapeutics in the USA. The product is an extended-release capsule, to be taken once daily. The expiration date indicated is MMYYYY, with the lot number XXXXXXXXX.*
Structure - memantine001
Figure 1: Time course of the change from baseline in SIB score for patients completing 24 weeks of treatment. - memantine002
Figure 2: Cumulative percentage of patients completing 24 weeks of double-blind treatment with specified changes from baseline in SIB scores. - memantine003
Figure 3: Time course of the CIBIC-Plus score for patients completing 24 weeks of treatment. - memantine004
Figure 4: Distribution of CIBIC-Plus ratings at week 24. - memantine005
Not available.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.